Ivanti Patches 10 EPMM, Neurons for ITSM and Sentry Flaws Enabling RCE and Admin Access
Ivanti patches 10 flaws in EPMM, Neurons for ITSM, and Sentry, including two 9.8-rated unauthenticated RCEs in ITSM.
Ivanti released fixes for 10 vulnerabilities across Endpoint Manager Mobile, Neurons for ITSM, and Sentry, and said it was not aware of active exploitation at disclosure. The most severe are CVE-2026-12744 and CVE-2026-12745, unauthenticated deserialization RCEs rated 9.8 in Neurons for ITSM, alongside authenticated deserialization and missing-authorization RCEs rated up to 9.9. CVE-2026-18851 is an 8.8-rated EPMM privilege escalation to administrator, and CVE-2026-83527 is an 8.1-rated unauthenticated authentication bypass in Sentry granting administrative access. Ivanti said the ITSM weaknesses were found using large language models; Cloud/SaaS fixes shipped August 9, 2026, and on-premises patches are available from September 2026.
2026-008: Critical vulnerabilities in Ivanti Sentry
Ivanti patched Sentry: pre-auth OS command injection CVE-2026-10520 (CVSS 10) enables unauthenticated root RCE, and auth bypass CVE-2026-10523 (CVSS 9.9).
On 9 June 2026 Ivanti released an advisory fixing two critical flaws in Ivanti Sentry versions 10.5.1 and prior, 10.6.1 and prior, and 10.7.0 and prior. CVE-2026-10520 (CVSS 10.0) is an OS command injection allowing a remote unauthenticated attacker to achieve root-level RCE. CVE-2026-10523 (CVSS 9.9) is an authentication bypass letting an unauthenticated attacker create arbitrary administrative accounts and obtain full admin access. CERT-EU recommends updating appliances to fixed versions following Ivanti's guidance.
Ivanti EPMM, Neurons and Sentry Vulnerabilities Enable Privilege Escalation and RCE Attacks
Ivanti patched ten CVEs across EPMM, Neurons for ITSM and Sentry, including critical unauthenticated deserialization RCE; no active exploitation reported.
On September 8, 2026, Ivanti disclosed advisories covering ten CVEs in Endpoint Manager Mobile (EPMM), Neurons for ITSM, and Sentry. The most severe are two unauthenticated deserialization RCE flaws in Neurons for ITSM, CVE-2026-12744 and CVE-2026-12745 (CVSS 9.8), plus three missing-authorization RCE bugs rated 9.9 and three authenticated deserialization RCE flaws. EPMM has CVE-2026-18851 (CVSS 8.8), an authenticated privilege escalation flaw, and Sentry has CVE-2026-83527 (CVSS 8.1), an authentication bypass. Ivanti reports no evidence of active exploitation; cloud/SaaS ITSM was patched on August 9, 2026, while on-premises 2025.2 through 2026.1 require September 2026 patches.
Ivanti Patches Critical Flaws Across Enterprise Security Products
Ivanti released September updates fixing six critical RCE flaws in Neurons for ITSM plus authentication bypasses in Sentry and EPMM; no exploitation seen.
Ivanti's September 2026 updates fix eight flaws in Neurons for ITSM, six of them critical remote code execution bugs with CVSS scores up to 9.9, including missing authorization issues (CVE-2026-12647, CVE-2026-12645, CVE-2026-12646) and deserialization flaws (CVE-2026-12650, CVE-2026-12744, CVE-2026-12745). Sentry releases R10.8.2, R10.7.3, and R10.6.4 patch CVE-2026-83527, an unauthenticated high-severity authentication bypass, while EPMM versions 12.10.0.0, 12.9.0.2, and 12.8.0.4 fix the authenticated bypass CVE-2026-18851. Ivanti says it is not aware of any exploitation in the wild. Citrix separately patched two medium-severity flaws in Workspace app for Windows.
Ivanti security advisory (AV26-897)
Canada's Cyber Centre relayed Ivanti's September 2026 security updates for Endpoint Manager Mobile, Neurons for ITSM, and Sentry, urging administrators to patch.
The Canadian Centre for Cyber Security forwarded Ivanti's September 2026 security updates covering Endpoint Manager Mobile, Neurons for ITSM (cloud/SaaS and on-prem), and Sentry. Affected releases include Endpoint Manager Mobile prior to 12.10.0.0, Sentry prior to R10.8.2, and Neurons for ITSM on-prem prior to 2026.2. The advisory references CVE-2026-18851 for Endpoint Manager Mobile and CVE-2026-83527 for Sentry, plus multiple CVEs in Neurons for ITSM. No exploitation is described in the advisory text.
GPT-5.6 Luna vs. GPT-6 Astra: Is a $1.20 Model Good Enough for Code Review?
Entelligence benchmarks GPT-5.6 Luna ($1.20/M output) against GPT-6 Astra for code review: Luna found 69 verified bugs at 3.6% of Astra's cost.
Entelligence compared GPT-5.6 Luna ($0.20/$1.20 per million tokens) against GPT-6 Astra ($10/$50) on 50 benchmark pull requests from Cal.com, Sentry, Discourse, Keycloak, and Grafana. Astra verified 92 bugs versus Luna's 69, with precision of 96% versus 74%, and Astra caught 19 of 24 security bugs while Luna found only 9. Luna cost $0.20 total versus Astra's $5.66 and reviewed faster at 23 seconds versus 36, with the widest quality gap on Keycloak authentication and permission logic (6 vs 14 verified bugs). Running both models would find 82% of the 143 verified bugs for $5.86 total.